New Voltage-dependent Potassium Channel And Its Use To Develop Therapeutic Medicine


The full document isn't yet available to us from the patent office.


Potassium channel protein (I) Kv6.2 is new. (I) has a sequence of 467 (human) or 482 (murine) amino acids (given in the specification) or is a homolog, derivative or fragment of these with the same electrobiological, pharmacological and/or biological activity, and/or immunogenicity. Independent claims are also included for the following: (1) potassium channel (A) containing at least one (I); (2) nucleic acid (II) encoding (I); (3) vector containing at least one copy of (II); (4) host cells transformed with this vector; (5) recombinant production of potassium channels by culturing eukaryotic cells of (4); (6) identifying and testing substances (A) that can open, close, or (in)activate potassium channels, or alter their biophysical properties; and (7) antibodies (Ab) that bind to (I).


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 16, 2008
  • Application: Aug 6, 1999
    EP EP 08004552 A
  • Priority: Aug 6, 1999
    EP EP 99941625 A
  • Priority: Aug 6, 1998
    DE DE 19841413 A

Download Citation

Sign in to the Lens